Document:

EXHIBIT
10.17 

 

FORM
OF PLACEMENT AGENT AGREEMENT

 

December
__, 2018

 

This
Placement Agent Agreement (“Agreement”) is made by and between Pacific Ventures Group, Inc., a Delaware corporation
(the “Company”), and one or more placement agents (collectively, the “Placement Agents” and each, a “Placement
Agent” as of the date first above written. The Company agrees to engage each of the Placement Agents to assist the Company
as its Placement Agents in a non-exclusive capacity in arranging an offering of its 11% Series G Cumulative Redeemable Perpetual
Preferred Stock (the “Series G Preferred Stock” of the “Securities”) which will be subject to a registration
statement (the “Registration Statement”) on Form S-1 to be filed with the United States Securities and Exchange Commission
(the “SEC”), on terms set forth in the Registration Statement with respect to the offering of the Series G Preferred
Stock (the “Offering”). The terms of the Offering will be more fully described in the Registration Statement and the
Certificate of Designation filed as an exhibit to the Registration Statement pertaining to the Offering.

 

NOW
THEREFORE, based on the foregoing and the mutual covenants set forth below and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Company and the respective Placement Agents do hereby agree as follows:

 

1. Services.

 

(a)
The Placement Agent(s) shall offer participation in the Offering to its clients and other qualified persons with whom the Placement
Agent(s) or the Company or any of their respective officers, directors, employees or affiliates has a pre-existing business relationship
(“Qualified Investors”) and that the Placement Agent(s) reasonably believe are Qualified Investors. Any such potential
Qualified Investor in the Offering, including entities controlled by or advised by the Placement Agent(s) and their respective
affiliates, that is first introduced to the Company by the Placement Agent(s) shall be considered a Qualified Investor. A list
of Qualified Investors will be provided to the Company within five (5) business days of the final closing of the Offering and
it is expressly understood that Placement Agent(s) will only contact those institutions which have been preapproved by the Company
which approval will not be unreasonably withheld, or whom the Placement Agent(s) have reason to believe satisfy the requirements
to be deemed to be a Qualified Investor.

 

(b)
The Company shall be responsible for (i) the Registration Statement, as well as the relevant subscription documents or securities
purchase agreement (the “Transaction Documents”), and related investment materials to be used in connection with the
Offering; and the Placement Agent(s) shall be responsible for (i) organizing, obtaining facilities for, and conducting one or
more investor presentations and (ii) providing other services reasonably related to serving as the Placement Agent(s) for the
Company in connection with the Offering.

 

(c)
The Company shall (1) make members of management and other employees available to the Placement Agent(s) as the Placement Agent(s)
shall reasonably request for purposes of satisfying the Placement Agent(s)’s due diligence requirements and providing assistance
in consummating the Offering; (2) make its key management and sales members available to attend a reasonable number of investor
presentations, as recommended by the Placement Agent(s); and (3) commit such time and other resources as are reasonably necessary
or appropriate to support the Placement Agent(s) in its efforts to secure the reasonable and timely success of the Offering. The
Company shall cooperate with the Placement Agent(s) in connection with and shall make available to the Placement Agent(s) such
documents and other information as the Placement Agent(s) shall reasonably request in order to satisfy, its due diligence requirements,
subject to any applicable confidentiality requirements.

 

(d)
The Placement Agent(s) acknowledges that (i) the Company may determine, in its sole discretion, whether to accept an offer of
subscription to the Offering by a Qualified Investor and (ii) the Company is not obligated to compensate the Placement Agent(s)
for such offered subscriptions to the Company that the Company does not accept.

 

(e)
The Company acknowledges that the Placement Agent(s) may engage one or more sub-agents (each a “Sub-Agent”), reasonably
acceptable to the Company, to assist the Placement Agent(s) in the placement of the Securities. Each Sub-Agent will be assigned
a portion of the Cash Fee and Equity Compensation (as each is defined below) otherwise payable to the Placement Agent(s), in the
amounts, and on the terms set forth in an agreement between the Placement Agent(s) and Sub-Agent(s) and for which amounts shall
be paid to the Sub-Agent(s) by the Placement Agent(s).

  

    1

     

    

 

2. Compensation
Payable to the Placement Agent(s).

 

(a)
The Company shall, at each closing of the Offering (each a “Closing”), as compensation for the services provided by
the Placement Agent(s) hereunder, pay the Placement Agent(s) a cash commission equal to seven (7%) percent of the gross proceeds
received by the Company from Qualified Investors from such closing (the “Cash Fee”) as a direct result of the selling
efforts and introductions of each respective Placement Agent.

 

(b)
At the final Closing of an of the sale of shares of the Company’s Series G Preferred Stock, the Placement Agent(s) shall
be entitled to receive a warrant to purchase a number of shares of the Company’s Common Stock (“Placement Agent Warrants”),
equal to seven (7%) percent of the number of shares of Series G Preferred Stock sold in the Offering as a direct result of the
selling efforts and introductions of each respective Placement Agent, during the period of thirty-six (36) months from the final
Closing of the Offering an exercise price equal to a premium of twenty (20%) percent above the average closing price of the Company’s
Common Stock during the period of twenty (20) trading days prior to the Closing. The Placement Agent(s) may assign Placement Agent
Warrants to Sub-Agents, or other designees, so long as such designees are accredited investors and execute such certificates reasonably
requested by the Company to ensure compliance with applicable securities laws.

 

3. Term.

 

(a)
Unless earlier terminated as set forth herein, this Agreement will continue in full force and effect for a term expiring on ___________,
2019, unless extended by the Company and the Placement Agent(s) (the “Term”). Certain provisions of this Agreement
survive the termination of this Agreement as expressly provided elsewhere herein.

 

(b)
Prior to the end of the Term, (i) the Company may terminate this Agreement immediately and without notice in the event of a material
breach of this Agreement by the Placement Agent(s), and (ii) either party may terminate this Agreement upon three (3) business
days prior written notice to the other party for any reason. In the event the Company terminates this Agreement, the Placement
Agent(s) will be entitled to all applicable Cash Fees and Equity Compensation provided for in Section 2 hereof, earned prior to
such termination.

 

4. Performance.
In connection with the performance of its duties under this Agreement, the Placement Agent(s) agrees as follows:

 

(a)
The Placement Agent(s) shall act in a manner consistent with the instructions of the Company and comply with all applicable laws,
whether foreign or domestic, of each jurisdiction in which the Placement Agent(s) proposes to carry on the business contemplated
by this Agreement. The Placement Agent(s) shall not take any action or omit to take any action that would cause the Company to
violate any law or to jeopardize the availability of any applicable exemption from registration under the Act or the Securities
Exchange Act of 1934 (the “Exchange Act”). The Placement Agent(s) is a member firm in good standing of the Financial
Industry Regulatory Authority, Inc. (“FINRA”) and has all authority and approvals needed to engage in securities trading
and brokerage activities, as well as providing investment banking and financial advisory services. The Placement Agent(s) represents,
warrants and agrees that it shall at all times provide its services under this Agreement in compliance with applicable law.

 

(b)
The Placement Agent(s) shall, and shall cause all Sub-Agents to, keep a record of, and when and to whom each Registration Statement
is provided.

 

(c)
The Placement Agent(s) shall only provide the Registration Statement to potential investors and shall not make any additional
statements that contain an untrue statement of a material fact or omit to state any fact necessary to make any statement made
by the Placement Agent(s) not misleading in light of the circumstances in which such statements are made.

  

    2

     

    

 

(d)
The Placement Agent(s) shall not provide any other information about the Company to any person or firm that, to the knowledge
of the Placement Agent(s), is a competitor of the Company or is an officer, director, employee, affiliate or investor in a competitor
of the Company.

 

(e)
The Placement Agent(s) shall use its best efforts to cause its officers, directors, employees and affiliates to comply with all
of the foregoing provisions of this Section 4.

 

5. Representations
and Warranties of the Parties.

 

(a)
The Company represents and warrants to the Placement Agent(s), except as otherwise set forth in the Company’s filings with
the Securities and Exchange Commission (the “Exchange Act Reports”), as follows:

 

(i)
On the effective date of the Registration Statement and at each Closing, the Registration Statement will comply in all material
respects with the disclosure requirements of Act and will neither contain any untrue statements of a material fact or omit to
state a material fact required to be stated therein in light of the circumstances under which they are made, or necessary to make
the statements therein not misleading.

 

(ii)
The financial statements included in the Registration Statement present fairly in all material respects the financial position
of the Company as of the dates indicated and the results of its operations for the periods specified.

 

(iii)
The Company has been duly formed and is validly existing as a corporation in good standing under the laws of the State of Delaware,
with the power and authority to own, lease and operate its properties and conduct its business in all material respects as described
in the Registration Statement; and the Company is duly qualified as a foreign entity to transact business and is in good standing
in each jurisdiction in which the conduct of its business and/or its ownership of property requires such qualification except
for such jurisdictions in which the failure to qualify in the aggregate would not have a material and adverse effect on the results
of operations or financial conditions of the Company.

 

(iv)
Except as disclosed in the Registration Statement or the Company’s reports under the Exchange Act (the “Exchange Act
Reports”), the Company does not have any subsidiaries and does not own any interest in any other corporation, partnership,
joint venture or other entity.

 

(v)
This Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and binding agreement,
enforceable in accordance with its terms, except as enforceability of any indemnification provision may be limited under federal
securities laws and except as enforceability of such agreements may be limited by applicable bankruptcy, reorganization, insolvency,
moratorium or other laws relating to or affecting generally the enforcement of creditors’ rights.

 

(vi)
On the effective date of the Registration Statement and at each Closing, the Company owns good and marketable title to all properties
and assets described in the Registration Statement as owned by it, free and clear of all liens, charges, encumbrances or restrictions,
except such as are described or referred to in the Registration Statement or are not materially significant or important in relation
to the business of the Company.

 

(vii)
Except as disclosed in or contemplated by the Registration Statement or the Exchange Act Reports, the Company is not in violation
of its Certificate of Incorporation or its Bylaws, or in default in the performance or observance of any material obligation,
agreement, covenant or condition contained in any material bond, debenture, note or other evidence of indebtedness or in any material
contract, indenture, mortgage, loan agreement, lease, joint venture or other agreement or instrument to which the Company is a
party or by which it or any of its properties are bound; and the execution and delivery of this Agreement, the incurrence of the
obligations herein set forth and the consummation of the transactions herein contemplated will not conflict in any material respect
with, or result in a breach of any of the material terms, conditions or provisions of, or constitute a material default under,
the Certificate of Incorporation or Bylaws of the Company, or any material bond, debenture, note or other evidence of indebtedness
or any material contract, indenture, mortgage, loan agreement, lease, joint venture or other agreement or instrument to which
the Company is a party or by which it or any of its properties are bound.

  

    3

     

    

 

(viii)
Except as disclosed in or contemplated by the Registration Statement or the Exchange Act Reports, there is no material action,
suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge
of the Company, threatened against or affecting the Company, which might result in any material and adverse change in the condition
(financial or otherwise), business or prospects of the Company.

 

(ix)
Except as disclosed in or contemplated by the Registration Statement, each material contract to which the Company is a party is
in full force and effect or has terminated in accordance with its terms or as set forth in the Registration Statement; and no
party to any such contract has given notice of the cancellation of, or to the knowledge of the Company has the intention to, cancel
any such material contract.

 

(x)
Except as disclosed in or contemplated by the Registration Statement and the fees and disbursements payable to the Placement Agent(s)
pursuant to this Agreement, there are no outstanding claims for services either in the nature of a finder’s fee, brokerage
fee or other similar fee with respect to the Offering for which the Company or the Placement Agent(s) may be responsible.

 

(b)
The Placement Agent(s) represents and warrants to and covenants with the Company that:

 

(i)
The Placement Agent(s) is a limited liability company duly organized, validly existing and in good standing under the laws of
the State of Oregon and it has all requisite power and authority to enter into this Agreement and to carry out its obligations
hereunder.

 

(ii)
This Agreement has been duly authorized, executed and delivered by the Placement Agent(s) and on its behalf and constitutes a
valid and legally binding obligation enforceable against the Placement Agent(s) in accordance with its terms.

 

(iii)
The execution and delivery of this Agreement, the observance and performance hereof and the consummation of the transactions contemplated
hereby and by the Registration Statement do not and will not result in any breach of, or default under, any instrument or agreement
by which the Placement Agent(s) is bound or violate any law or order directed to the Placement Agent(s) of any court or any federal
or state regulatory body or administrative agency having jurisdiction over the Placement Agent(s) or over its property.

 

(iv)
The Placement Agent(s) is duly registered as a broker-dealer with the SEC pursuant to the Exchange Act, and no proceeding has
been initiated to revoke any of such registrations; the Placement Agent(s) is a member in good standing of FINRA; the Placement
Agent(s) is duly registered as a broker-dealer under the applicable statutes, if any, in each state in which the Placement Agent(s)
proposes to offer or sell the Securities where such registration is required; the Placement Agent(s) shall be responsible for
payment of compensation owed to any Sub-Agent(s), if any, which Sub-Agent(s), if any, must be a member in good standing of FINRA
and registered in each state where investors identified by such Sub-Agent(s) reside.

 

(v)
The Placement Agent(s) shall maintain all broker-dealer registrations, referred to above in paragraph (iv), throughout the period
in which Securities are offered and sold; the Placement Agent(s) has complied and will comply with all broker-dealer requirements
applicable to this transaction; the Placement Agent(s) is not in violation of any order of any court or regulatory authority applicable
to it with respect to the sale of the Securities.

 

(vi)
Neither the Placement Agent(s) nor any of its representatives is authorized to make any representation on behalf of the Company
other than those contained in the Registration Statement or any additional information expressly provided by the Company to the
Placement Agent(s) for dissemination to potential investors, nor is the Placement Agent(s) or any of its representatives authorized
to act as the agent or representative of the Company in any capacity, except as expressly set forth herein.

  

    4

     

    

 

(vii)
In the event that, on or before any Closing, the Placement Agent(s) becomes aware of any false statement of a fact or representation
in the Registration Statement, the Placement Agent(s) shall promptly inform the Company of such false statement of fact.

 

(viii)
The Placement Agent(s) shall inform the Company of each date on which it first receives any subscription from prospective investors
in each particular state where the Securities are offered and shall not offer the Securities for sale in any state in which the
offer or sale requires prior notice or clearance from any state securities commission, bureau or agency thereon, unless the Company
has confirmed that such prior notice or clearance has been made or obtained.

 

(ix)
It has not taken, and will not take, any action, directly or indirectly, that may cause the Offering to fail to be entitled to
exemption from applicable state securities or “blue sky” laws.

 

6. Indemnification.

 

(a)
The Company agrees to indemnify and hold harmless the Placement Agent(s), its officers, directors, partners, employees, agents,
legal counsel and any of its affiliates (each, a “Placement Agent’s Indemnified Party”) against any and all
losses, claims, damages, liabilities, joint or several, and expenses (including all legal or other expenses reasonably incurred
by a Placement Agent’s Indemnified Party) caused by or arising out of any misrepresentation or untrue statement or alleged
misrepresentation or untrue statement of a material fact contained in the Registration Statement or any other document furnished
by the Company to the Placement Agent(s) for delivery to or review by the Qualified Investors, or the omission or the alleged
omission to state in such documents furnished to the Qualified Investors a material fact necessary in order to make the statements
therein not misleading in light of the circumstances under which they were made, to the extent such misstatements or omissions
are made in reliance upon and in conformity with written information furnished by the Company for use in the documents furnished
to the Qualified Investors, including the Registration Statement (except to the extent such misrepresentations, untrue statements
or omissions are based on information provided to the Company by the Placement Agent(s) or its/their affiliates). The Company
agrees to reimburse the Placement Agent’s Indemnified Party for any reasonable expenses (including reasonable fees and expenses
of counsel) incurred as a result of producing documents, presenting testimony or evidence, or preparing to present testimony or
evidence (based upon time expended by the Placement Agent’s Indemnified Party at its then current time charges or if such
person shall have no established time charges, then based upon reasonable charges), in connection with any court or administrative
proceeding (including any investigation which may be preliminary thereto) arising out of or relating to the performance by the
Placement Agent’s Indemnified Party of any obligation hereunder and relating to a matter for which the Company must provide
indemnity to or hold harmless such Placement Agent’s Indemnified Party pursuant to the provisions of this subsection 6(a).
In the event the Company shall be obligated to indemnify a Placement Agent’s Indemnified Party in connection with any such
proceeding, the Company shall be entitled to assume the defense of such proceeding, with counsel approved by the Placement Agent’s
Indemnified Party (which shall not be unreasonably withheld), upon the delivery to the Placement Agent’s Indemnified Party
of written notice of the Company’s election to do so.

 

(b)
The Placement Agent(s), individually but not collectively, agree to indemnify and hold harmless the Company, its managers, officers,
directors, partners, employees, agents, legal counsel and its affiliates (each, a “Company Indemnified Party”) against
any and all losses, claims, damages and liabilities, joint or several, and expenses (including all legal or other expenses reasonably
incurred by a Company Indemnified Party) caused by or arising out of any misrepresentation or untrue statement or alleged misrepresentation
or untrue statement of a material fact made by the Placement Agent(s) or its affiliates to the Qualified Investors, or any Placement
Agent’s omission or the alleged omission to state to the Qualified Investors a material fact necessary in order to make
statements made not misleading in light of the circumstances under which they were made (except to the extent such misrepresentations,
untrue statements or omissions are based on information provided to the Placement Agent(s) by the Company, including the Registration
Statement or any other document furnished by the Company to the Placement Agent(s) for delivery to or review by the Qualified
Investors), in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission
or alleged omission was made in the Registration Statement or other document furnished to the Placement Agent(s) for delivery
to or review by the Qualified Investors, in reliance upon and in conformity with written information furnished to the Company
by the Placement Agent or its affiliates expressly for use therein. The Placement Agent(s) agrees to reimburse the Company Indemnified
Party for any reasonable expenses (including reasonable fees and expenses of counsel) incurred as a result of producing documents,
presenting testimony or evidence, or preparing to present testimony or evidence (based upon time expended by the Company Indemnified
Party at its then current time charges or if such person shall have no established time charges, then based upon reasonable charges),
in connection with any court or administrative proceeding (including any investigation which may be preliminary thereto) arising
out of or relating to the performance by the Company Indemnified Party of any obligation hereunder and relating to a matter for
which the Company must provide indemnity to or hold harmless such Company Indemnified Party pursuant to the provisions of this
subsection 6(b). The Placement Agent(s)’ obligations under this Section 6(b) shall be limited to the net amount of Cash
Fees paid or payable by the Company to the Placement Agent(s), other than in the case of fraud, intentional misrepresentation
or willful breach. In the event the Placement Agent(s) shall be obligated to indemnify a Company Indemnified Party in connection
with any such proceeding, the Placement Agent(s) shall be entitled to assume the defense of such proceeding, with counsel approved
by the Company Indemnified Party (which shall not be unreasonably withheld), upon the delivery to the Company Indemnified Party
of written notice of the Placement Agent(s)’ election to do so.

  

    5

     

    

 

(c)
In order to provide for just and equitable contribution under the Act in any case in which (i) any person entitled to indemnification
under this Section 6 makes claim for indemnification pursuant hereto but it is judicially determined (by the entry of a final
judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of
appeal) that such indemnification may not be enforced notwithstanding the fact that this Section 6 provides for indemnification
in such case, or (ii) contribution under the Act may be required on the part of any such person in circumstances for which indemnification
is provided under this Section 6, then, and in each such case, the Company and the Placement Agent(s) shall contribute to the
aggregate losses, claims, damages or liabilities to which they may be subject (after any contribution from others) in such proportion
so that the Placement Agent(s) is responsible for the proportion that the amount of commissions appearing in the Registration
Statement bears to the price appearing therein, and the Company is responsible for the remaining portion; provided, that, in any
such case, no person guilty of a fraudulent misrepresentation or omission (within the meaning of Section 11(f) of the Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

(d)
The respective indemnity agreements between the Placement Agent(s) and the Company contained in Sections 6(a) and (b) of this
Agreement, and the representations and warranties of the parties set forth in Section 5 or elsewhere in this Agreement, shall
remain operative and in full force and effect, regardless of any investigation made by or on behalf of the Company or Placement
Agent(s), as the case may be, or by or on behalf of any controlling person of the Placement Agent(s) or the Company or any such
manager, partner, officer or director or any controlling person of the Company or the Placement Agent(s), as the case may be,
and shall survive the delivery of the Securities, and any successor of the Company and of the Placement Agent(s), or of any controlling
person of the Company or the Placement Agent(s), as the case may be, shall be entitled to the benefit of the respective indemnity
agreements. The representations and warranties in Section 5 of this Agreement (but not the indemnities contained in Section 6
hereof) shall terminate six (6) months after the final Closing under this Agreement.

 

7. Covenants

 

(a)
The Company covenants with the Placement Agent(s) as follows:

 

(i)
The Company will notify the Placement Agent(s) promptly, and confirm the notice in writing, of the initiation by the Commission
or any state securities commission of any proceeding against the Company.

 

(ii)
The Company will give the Placement Agent(s) notice of its intention to amend or supplement the Registration Statement.

 

(iii)
If any event shall occur as a result of which it is necessary, in the reasonable opinion of either or both of the Placement Agent(s)
and the Company, to amend or supplement the Registration Statement in order to make the Registration Statement not misleading
in the light of the circumstances existing at the time it is delivered to a purchaser, the Company will forthwith amend or supplement
the Registration Statement by preparing and furnishing to the Placement Agent(s) a reasonable number of copies of an amendment
or amendments of, or a supplement or supplements to, the Registration Statement (in form and substance satisfactory to the Placement
Agent(s)), so that, as so amended or supplemented, the Registration Statement will not contain an untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing
at the time it is delivered to a purchaser, not misleading.

  

    6

     

    

 

(iv)
The Company will endeavor, in cooperation with the Placement Agent(s), to qualify or perfect an exemption for the Securities for
offering and sale under the applicable securities laws of such states and other jurisdictions of the United States as the Placement
Agent(s) and the Company agree to offer and sell the Securities, and will maintain such qualifications in effect for so long as
may be required for the distribution of the Securities. This will include, but not be limited to preparing and filing Forms D,
and notice filings with each State, as, if, and when appropriate.

 

(v)
The Company will apply the net proceeds from the sale of the Securities sold by it hereunder substantially as contemplated by
the Registration Statement.

 

(vi)
All communications by the Company with the Placement Agent(s) shall be with the Placement Agent’s President, legal counsel
and/or designated investment banker(s) with respect to the Offering. The Company shall not initiate communication directly with
any of the Placement Agent’s brokers or the Qualified Investors (until such time as such Qualified Investors are stockholders
of the Company) without the prior consent of the Placement Agent(s).

 

(b)
The Placement Agent(s) covenants and agrees that:

 

(i)
It will not give any information or make any representation in connection with the offering of Securities which is not contained
in the Registration Statement.

 

(ii)
In making any offer of Securities, the Placement Agent(s) agrees that it will comply with the provisions of the Act and the Exchange
Act and the securities laws of each state, and that it and its authorized agents will offer to sell, or solicit offers to subscribe
for or buy, the Securities only in those states and other jurisdictions in the United States in which such solicitations can be
made in accordance with an applicable exemption from registration or qualification and in which the Placement Agent(s) is qualified
to so act. Nothing contained herein shall limit the Placement Agent(s) from offering to sell the Securities outside the United
States in compliance with applicable laws.

 

8. Confidentiality.
Except in keeping with its obligations under this Agreement, the Placement Agent(s) will maintain in confidence and will use only
for the purpose of fulfilling its obligations hereunder and will not use for its own benefit any inventions, confidential know-how,
trade secrets, financial information and other non-public information and data disclosed to it by the Company, and it will not
divulge the same to any other persons until such time as the information becomes a matter of public knowledge. The Placement Agent(s)
will use its best efforts to prevent any unauthorized disclosure described above by others.

 

9. Independent
Contractor; Duty Owed.

 

(a)
The Placement Agent(s) will perform its services hereunder as an independent contractor, and nothing in this Agreement will in
any way be construed to constitute the Placement Agent(s) the agent, employee or representative of the Company. Neither the Placement
Agent(s) nor any agent acting on behalf of the Placement Agent(s) will enter into any agreement or incur any obligations on the
Company’s behalf or commit the Company in any manner or make any representations, warranties or promises on the Company’s
behalf or hold itself (or allow itself to be held) as having any authority whatsoever to bind the Company without the Company’s
prior written consent, or attempt to do any of the foregoing.

 

(b)
The Company acknowledges that the Placement Agent(s) is being engaged hereunder solely to provide the services described above
to the Company, and that it is not acting as a fiduciary of, and shall have no duties or liabilities to, the equity holders of
the Company or any other third party in connection with its engagement hereunder, all of which are hereby expressly waived.

  

    7

     

    

 

10. General.

 

(a) Arbitration.
The parties hereto agree that any dispute or controversy arising out of, relating to or concerning any interpretation, construction,
performance or breach of this Agreement, shall be subject to the laws of the State of New York without giving effect to its conflicts
of laws provisions. Any disputes will be settled in binding arbitration in New York County, City and State of New York under the
auspices of FINRA dispute resolution. The decision of the arbitrator will be final, conclusive and binding on the parties to the
arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The Company and the
Placement Agent(s) shall each pay one-half of the costs and expenses of such arbitration, and each shall separately pay its counsel
fees and expenses.

 

(b) Covenant
against Assignment. This Agreement is personal to the parties hereto, and accordingly, except for the right to enforce the
obligations under Sections 6 and 7 hereunder (which right shall inure to the benefit of the successors and assigns of the aggrieved
party), neither this Agreement nor any right hereunder or interest herein may be assigned or transferred or charged by either
party without the express written consent of the other.

 

(c) Entire
Agreement; Amendment. This Agreement and the attached exhibits constitute the entire contract between the parties with respect
to the subject matter hereof and supersede any prior agreements between the parties. This Agreement may not be amended, nor may
any obligation hereunder be waived, except by an agreement in writing executed by, in the case of an amendment, each of the parties
hereto, and, in the case of a waiver, by the party waiving performance.

 

(d) No
Waiver. The failure or delay by a party to enforce any provision of this Agreement will not in any way be construed as a waiver
of any such provision or prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted
the parties hereunder are cumulative and will not constitute a waiver of either party’s right to assert any other legal
remedy available to it.

  

(e) Severability.
Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions will nevertheless remain
effective and will remain enforceable to the greatest extent permitted by law.

 

(f) Notices.
Any notice, demand, offer, request or other communication required or permitted to be given by either the Company or the Placement
Agent(s) pursuant to the terms of this Agreement must be in writing and will be deemed effectively given the earlier of (i) when
received, (ii) when delivered personally, (iii) one business day after being delivered by facsimile (with receipt of appropriate
confirmation) to the number provided to the other party or such other number as a party may request by notifying the other in
writing, (iv) one business day after being deposited with an overnight courier service or (v) four days after being deposited
in the U.S. mail, First Class with postage prepaid, and addressed to the party at the address previously provided to the other
party or such other address as a party may request by notifying the other in writing.

 

(g) Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together
will constitute one and the same agreement. Facsimile copies of signed signature pages will be deemed binding originals.

 

[Signatures
on Following Page]

  

    8

     

    

 

SIGNATURE
PAGE TO PLACEMENT AGENT AGREEMENT

 

The
parties have executed this Placement Agent Agreement as of the date first written above.

 

	PACIFIC
    VENTURES GROUP, INC.	 
	 	 	 
	/s/:
    Shannon Masjedi	 
	Name: 	Shannon
    Masjedi	 
	Title:	Chief
    Executive Officer	 

 

PLACEMENT
AGENTS:

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

 

By:
____________________

Placement
Agent: ________________________

Name:
__________________

Title:
___________________

  

    9Exhibit 10.1

    

    

    SUPPLY AND MARKETING COLLABORATION AGREEMENT

    

    

    This Supply and Marketing Collaboration Agreement (this “Agreement”)

        entered into on October 1, 2018 (the “Effective Date”), by and between Cibus
          US LLC, a limited liability company organized and existing under the laws of Delaware having a place of business at 6455 Nancy Ridge Drive, San Diego, California 92121, United States and Cibus Europe B.V., a Netherlands Besloten Vennootschap organized and existing under the laws of the Netherlands having a place of business at Goessestraatweg 19, 4421 AD Kapelle, Netherlands (collectively
        herein referred to as “Cibus”), and Amaethon Environmental Limited, a
        corporation organized and existing under the laws of the British Virgin Islands having its principal place of business at P.O. Box 2208, Road Town, Tortola, British Virgin Islands (herein referred to as “Rotam”); Cibus and Rotam are sometimes referred to individually as a “Party” and collectively as the “Parties”).

    

    

    RECITALS

     

        

    WHEREAS, Cibus has developed sulfonylurea (“SU”) tolerant canola for sale as Cibus branded seed and may license the SU tolerance trait to third party seed companies;

    

    

    WHEREAS, Cibus has expertise and extensive
        experience in the testing, marketing, production and distribution of SU tolerant canola and has established distribution systems and relationships for the sale and stewardship of canola seed;

    

    

    WHEREAS, Rotam has expertise and extensive
        experience in the testing, marketing, production and distribution of SU herbicides and has established distribution systems and relationships with dealers for the sale and stewardship of SU herbicides;

    

    

    WHEREAS, Rotam has been commercially active in
        chemical registration and chemical international FTO, and has supported Cibus with the SU tolerant canola system in obtaining SU herbicide registrations and supplying SU herbicides for use with SU tolerant canola;

    

    

    WHEREAS, the Parties wish to continue with their
        supply and marketing collaboration of the SU tolerant canola system; and

    

    

    NOW, THEREFORE, in consideration of the foregoing
        recitals, the mutual benefits and covenants contained herein and other good and valuable consideration, the Parties hereby agree as follows:

    

    

    
      1

      
        

    

    

    

    ARTICLE 1.   DEFINITIONS

     

          

    
      
        	

              	1.1	
                “AAA” has the meaning set forth in Section 10.2(b).

              

      

    

    

    

    
      
        	

              	1.2	
                “Affiliate” means any corporation, firm, limited liability company, partnership or
                    other entity that directly or indirectly controls, is controlled by, or is under common control with a Party, “control” meaning in this context the
                    direct or indirect (through one or more affiliates) ownership of fifty percent (50%) or more of the shares of stock entitled to vote for the election of directors, in the case of a corporation, or fifty percent (50%) or more of the
                    equity interests in the case of any other type of legal entity, status as a general partner in any partnership, or any other arrangement whereby a Party controls or has the right to control the Board of Directors or equivalent governing
                    body of a corporation or other entity.

              

      

    

    

    

    
      
        	

              	1.3	
                “Canola” means open pollinated, synthetic, or hybrid cultivars of Brassica napus.

              

      

    

    

    

    
      
        	

              	1.4	
                “Cibus AHAS Trait” means any mutation in the Acetohydroxy Acid Synthase genes of Brassica napus wherein the mutation confers resistance to a sulfonylurea herbicide.

              

      

    

    

    

    
      
        	

              	1.5	
                “Commercially Reasonable” or “Commercially Reasonable Efforts” (whether or not capitalized) means any such action or amount that a company in the same business/industry would undertake in good faith considering all
                    factors/circumstances contemplated by the Parties such as cost, liability, responsibilities, risk and benefits received by each Party.  In considering what is “Commercially Reasonable”, a Party shall not expect the other Party to enter
                    into arrangements that would be an inappropriate burden to the company in such circumstances.

              

      

    

    

    

    
      
        	

              	1.6	
                “Development Plan” has the meaning set forth in Section 5.3(c)(2).

              

      

    

    

    

    
      
        	

              	1.7	
                “Dispute” has the meaning set forth in Section 10.1.

              

      

    

    

    

    
      
        	

              	1.8	
                “Commercialization Committee” has the meaning set forth in Section 5.3(c)(1).

              

      

    

    

    

    
      
        	

              	1.9	
                “Confidential Information” means all information, written, electronic, or oral, all
                    terms of this Agreement, all Cibus proprietary information, all Rotam proprietary information and all other proprietary or confidential information including and relating to, without limitation, the business, operations, plans,
                    services, facilities, processes, software, methodologies, technologies, intellectual property, research and development, clients and suppliers, partners, principals, employees, consultants, and authorized agents of either Party that is
                    supplied by or on behalf of the disclosing Party to the other Party.

              

      

    

    

    

    
      2

      
        

    

    

    

    
      
        	

              	1.10	
                “Experimental Use Permit” means a permit under FIFRA or the Canadian Pest Control
                    Products Act that authorizes the testing of new herbicides or uses thereof in experimental field studies on ten (10) acres or more of land or one acre or more of water. Such tests provide data to support registration of herbicides.

              

      

    

    

    

    
      
        	

              	1.11	
                “FIFRA” means the Federal Insecticide, Fungicide, and Rodenticide Act as amended.

              

      

    

    

    

    
      
        	

              	1.12	
                “Marketing Collaboration Term” has the meaning set forth in Section 3.1(a).

              

      

    

    

    

    
      
        	

              	1.13	
                “Negotiation Period” has the meaning set forth in Section 10.1.

              

      

    

    

    

    
      
        	

              	1.14	
                “Product Herbicide” means thifensulfuron, tribenuron, other sulfonylurea
                    herbicides, or combinations of the foregoing, having a Product Herbicide Label for use with Tolerant Product.

              

      

    

    

    

    
      
        	

              	1.15	
                “Product Herbicide Label” means the herbicide label approved by the US
                    Environmental Protection Agency (EPA) under FIFRA or the Canadian Pesticide Regulatory Management Agency (PMRA) under the Pest Control Products Act and attached to each herbicide container and includes the use of the Product Herbicide
                    on Tolerant Product.

              

      

    

    

    

    
      
        	

              	1.16	
                “Product Herbicide Registration” means a herbicide registration for the Product
                    Herbicide approved under FIFRA by the US EPA or the Pest Control Products Act by the Canadian PMRA and includes the Confidential Statement of Formula, EPA tolerance or PMRA Maximum Residue Level (MRL) for the Product Herbicide and the
                    use of the Product Herbicide on Tolerant Product.

              

      

    

    

    

    
      
        	

              	1.17	
                “Purpose” has the meaning set forth in Section 2.1.

              

      

    

    

    

    
      
        	

              	1.18	
                “SU” means sulfonylurea.

              

      

    

    

    

    
      
        	

              	1.19	
                “Supply Term” has the meaning set forth in Section 3.1(b).

              

      

    

    

    

    
      
        	

              	1.20	
                “Territory” means the United States and Canada.

              

      

    

    

    

    
      
        	

              	1.21	
                “Tolerant Product” means a commercial cultivar of Cibus branded Canola seed
                    developed using genetics that contain a Cibus AHAS Trait that Cibus has approved and selected for sale and use with Product Herbicide.

              

      

    

    

    

    

    

    
      3

      
        

    

    

    

    ARTICLE 2.   KEY COMMITMENTS

     

          

    
      
        	2.1.	
                Purpose. The Parties intend to continue with their supply and marketing collaboration, with
                    Cibus having the responsibility for developing and registering Tolerant Product and Rotam serving as the herbicide partner of Cibus for sourcing and distributing Product Herbicide intended for use with Tolerant Product in the Territory
                    (the “Purpose”).

                 

                  

              

      

    

    
      
        	
                2.2.

              	
                The Parties agree to engage in a long-term collaboration for the Purpose in the Territory where Cibus will have the right and responsibility for developing and registering
                    (i) Tolerant Product and the Cibus AHAS Trait and (ii) any non-herbicide tolerance trait when stacked with the Tolerant Product as decided solely by Cibus.

                 

                  

              

      

    

    
      
        	2.3.	
                Rotam will serve as the exclusive herbicide partner during the Marketing Collaboration Term and Supply Term (defined in Article 3 below) of (i) Tolerant Product, for
                    sourcing and distributing (directly and indirectly) the Product Herbicides and (ii) any non-herbicide tolerance trait when stacked with the Tolerant Product as decided solely by Cibus, except where Rotam is unable to supply Product
                    Herbicide and Cibus is required to activate the supplemental registration per Section 6.7.

                 

                  

              

      

    

    
      
        	2.4.	
                If Cibus elects to stack a non-herbicide tolerance trait in a Tolerant Product, the non-herbicide tolerance trait will be available without any development cost to Rotam
                    and without any value-sharing for Rotam.

                 

                  

              

      

    

    
      
        	2.5.	
                Cibus agrees to exclusively market and promote Rotam branded Product Herbicide for Tolerant Product during the Marketing Collaboration Term, which will be published in its
                    presentation, training and marketing material. Where Cibus licenses the Cibus AHAS Trait to third parties, Cibus agrees to exclusively recommend Rotam branded Product Herbicide for use by third-party licensees during the Marketing
                    Collaboration Term.

              

      

    

     

          

    ARTICLE 3.   TERM AND RENEWAL

     

          

    
      
        	3.1.	
                The term of this Agreement shall be separated into two (2) parts to govern (i) the marketing collaboration of the Purpose and (ii) the supply of Product Herbicide from
                    Rotam of the Purpose, and unless terminated in accordance with Article 7 below:

                 

                  

              

      

    

    
      
        	
                

                

              	(a)	
                Marketing Collaboration Term. The term of the marketing collaboration of the Purpose shall be
                    for a fixed period of three (3) years from the Effective Date (the “Marketing Collaboration Term”).  After the initial three (3) year period, the Marketing Collaboration Term will automatically renew for successive periods of one (1) year, unless either Party gives notice to the other
                    Party, at least a six (6) months’ notice not to renew.

              

      

    

    
      4

      
        

    

    

    

    
      
        	

              	(b)	
                Supply Term.  The term for the supply of Product Herbicide from Rotam of the Purpose shall be a
                    fixed period of five (5) years from the Effective Date (the “Supply Term”).  After the initial five (5) year period, the Supply Term will
                    automatically renew for successive periods of two (2) years, unless either Party gives notice to the other Party, at least a twelve (12) months’ notice not to renew.

                 

                  

              

      

    

    ARTICLE 4.   INTELLECTUAL
            PROPERTY

     

          

    
      
        	4.1.	
                All intellectual property rights relating to Tolerant Product, Cibus AHAS Trait, and any other traits developed by Cibus belong solely to Cibus and Cibus will be
                    responsible for securing and providing the intellectual property rights necessary to perform its responsibilities with respect to its intellectual property rights including Tolerant Product at its sole discretion.

                 

                  

              

      

    

    
      
        	4.2.	
                All Product Herbicide Registrations obtained by Rotam including its trademarks, irrespective of their use with the Tolerant Product belong solely to and is owned by Rotam.

                 

                  

              

      

    

    
      
        	4.3.	
                Cibus agrees not to directly or indirectly assist, advise, support, collaborate with or enable any third party to attempt to obtain one or more Experimental Use Permits
                    and/or Product Herbicide Registrations either for the benefit of Cibus or its Affiliates (save as expressly set out in Section 6.7) or any third party during the Marketing Collaboration Term covering use of a Product Herbicide with
                    Tolerant Product. In this regard, Cibus agrees not to provide third parties with samples of Tolerant Product, material having the Cibus AHAS Trait or any relevant Confidential Information during the Marketing Collaboration Term.

                 

                  

              

      

    

    
      
        	4.4.	
                Cibus also agrees not to support, collaborate with or participate in research or testing of any other third-party Product Herbicide with Tolerant Product and will assert
                    its intellectual property rights to prohibit any use of Cibus’ intellectual property rights to develop, manufacture, test, register or sell any such Tolerant Product by any third party during the Marketing Collaboration Term.

                 

                  

              

      

    

    
      
        	4.5.	
                Each Party shall have a non-exclusive, royalty-free license with a right to sub-license the use of the other Party’s logo and trademarks in the Territory in connection with
                    the marketing and sale of Tolerant Product in conjunction with Rotam owned Product Herbicide and in order to meet its obligations under this Agreement.  Such use of a Party’s logo and trademark shall require prior notification and
                    approval to the other Party, the approval of which will not be unnecessarily withheld.

                 

                  

              

      

    

    
      
        	4.6.	
                Each Party shall promptly notify the other Party upon knowledge or suspicion of any infringement of intellectual property rights owned by the other Party, which
                    infringement is materially relevant to this Agreement.

              

      

    

    
      5

      
        

    

    

    

    ARTICLE 5.   RESPONSIBILITIES
            OF THE PARTIES

     

          

    
      
        	5.1.	
                Cibus Responsibilities:

                 

                  

              

      

    

    
      
        	

              	(a)	
                Cibus retains discretion and responsibility for selection, testing, manufacture of and distribution of Tolerant Product and related Cibus AHAS Traits, provided it will make
                    those decisions in a Commercially Reasonable manner which is supportive of joint marketing plans between the Parties.

                 

                  

              

      

    

    
      
        	

              	(b)	
                Cibus retains the responsibility at its sole discretion to obtain such regulatory approvals and variety registrations as necessary to commercialize Tolerant Product in the
                    Territory.

                 

                  

              

      

    

    
      
        	

              	(c)	
                Cibus shall, at its sole discretion, have the responsibility in finding appropriate and qualified seed companies to license the Cibus AHAS Trait in the Territory and will
                    monitor specific seed production matters (e.g. germination, purity, SU tolerance level to Product Herbicide) and will ensure that the seeds produced will have a level of tolerance to the 2X labelled rate of the Product Herbicide that is
                    equal to or better than the current commercial Tolerant Product designated as the hybrid 68K or similar Tolerant Product hybrid as defined by Cibus.

                 

                  

              

      

    

    
      
        	

              	(d)	
                Cibus accepts all liabilities concerning specific seed production matters (e.g. germination, purity, level of tolerance to the 2X labelled rate of the Product Herbicide
                    that is equal to or better than the current commercial Tolerant Product designated as the hybrid 68K or similar Tolerant Product as defined by Cibus) for Tolerant Product and will indemnify Rotam for any related claims arising out of
                    such liability, provided that such claim has not arisen as a result of an intentional act, omission or negligence by Rotam.

                 

                  

              

      

    

    
      
        	

              	(e)	
                Where Cibus licenses the Cibus AHAS Trait to third parties pursuant to Section 2.5 and third-party branded seeds are used in conjunction with Product Herbicide, Cibus will
                    make Commercially Reasonable Efforts that such third party assume liability to licensee’s third-party branded seed and be set out in its licensing agreements and advise such third parties that separate agreements be entered into with
                    Rotam to include promotion of the third-party branded seed, the use of Product Herbicide for the third-party branded seed, appropriate agronomic practices and standards, stewardship and liabilities.  To assist Rotam to manage its
                    forecast with third party Cibus licensees, Cibus will provide to Rotam forecasts per Article 6 for their third party licensees which will be updated on a regular basis.

                 

                  

              

      

    

    
      
        	

              	(f)	
                Cibus will make Commercially Reasonable Efforts with such third parties to maintain the value of third-party branded seed which includes both the Cibus AHAS Trait value and
                    Product Herbicide costs.

              

      

    

    
      6

      
        

    

    

    

    
      
        	5.2.	
                Rotam Responsibilities:

                 

                  

              

      

    

    
      
        	

              	(a)	
                Rotam retains discretion and responsibility for selection, ensuring registration specification, testing, manufacture of and distribution of Product Herbicide in the
                    Territory, provided it will make those decisions in a Commercially Reasonable manner supportive of joint marketing plans between the Parties.

                 

                  

              

      

    

    
      
        	

              	(b)	
                Rotam shall retain the responsibility at its sole discretion to obtain such regulatory approvals as necessary, including export approval requirements of Tolerant Product
                    treated with Product Herbicide, to commercialize Product Herbicide in the Territory under a Product Herbicide Label that includes the use of the Product Herbicide on Tolerant Product.

                 

                  

              

      

    

    
      
        	

              	(c)	
                Rotam accepts all liabilities for its Product Herbicide such as weed control matters (e.g. efficacy, spraying and handling of chemicals) and matters concerning herbicide
                    manufacture (e.g., active ingredient specification and formulation) and will indemnify Cibus for any related claims arising out of such liability, provided that such claim has not arisen as a result of an intentional act, omission or
                    negligence by Cibus.

                 

                  

              

      

    

    
      
        	5.3.	
                Joint Responsibilities:

                 

                  

              

      

    

    
      
        	

              	(a)	
                Customer Complaint Resolution.  The Parties shall address and resolve all complaints received
                    from third parties. Any complaints received by farmers or retailers for Tolerant Product will be addressed by the Parties jointly where each Party agrees to visit the farmer or retailer (if feasible) in attempt to resolve the issue.  A
                    report on any complaints will be recorded in writing and to be addressed by the Parties within a reasonable period to reach a commercial resolution.

                 

                  

              

      

    

    
      
        	

              	(b)	
                Liability. Following any complaint procedure where any liability cannot be clearly determined
                    pursuant to Sections 5.1(d) and 5.2(c), the matter shall be referred to the leadership of the Parties as a Dispute pursuant to Section 10.1 and the Parties within the Negotiation Period (defined below) shall co-operate to facilitate
                    independent testing of Tolerant Product and Product Herbicide. The results of the tests shall be final. Where the results show joint liability, the Parties agree that the liability shall be shared equally.

                 

                  

              

      

    

    
      
        	

              	(c)	
                During the Marketing Collaboration Term, the Parties have the following additional joint responsibilities:

                 

                  

              

      

    

    
      
        	

              	(1)	
                Commercialization Committee. During the Marketing Commercialization Term, key principles for
                    commercialization of Tolerant Product and Product Herbicide will be decided upon and agreed using Commercially Reasonable Efforts by the Commercialization Committee which is already set up between the Parties. The Commercialization
                    Committee members will conduct at a minimum, quarterly meetings to discuss development, regulatory, marketing, costs, etc. that will be further defined in a Development Plan (referred to below). At each meeting the participation of two
                    (2) voting members shall constitute a quorum, with meetings to be adjourned in the absence of a quorum. A member from each Party will have one (1) vote each.  In the event that a deadlock occurs that cannot be resolved, the action will
                    be a Dispute to be dealt with in accordance with Section 10.1.

              

      

    

    
      7

      
        

    

    

    

    
      
        	

              	(2)	
                Development Plan.  The Parties will define a long-term five (5) year plan to support the
                    development and commercialization of the Product Herbicide for use on the Tolerant Product and other non-herbicide traits of the Tolerant Product. The plan will include FTE and funding levels along with activities of each Party such as
                    technical field trials and grower demo sites, regulatory trials for new herbicide labels, marketing and promotional support, positioning and development of Tolerant Product and Product Herbicide, economical contribution of each Party,
                    complaint management, along with performance metrics and other required activities as defined and agreed to between the Parties. This five (5) year plan will be reviewed on an annual basis and approved by both Rotam and Cibus
                    leadership. Neither Party may act without the specific authority, guidance and request of the Commercialization Committee on matters to be decided upon by the Commercialization Committee.

                 

                  

              

      

    

    
      
        	

              	(3)	
                Stewardship Program. The Parties will define a stewardship program where the Parties shall
                    ensure that their customers, seed breeders, seed commercial companies, retailers, and farmers, will strictly follow the stewardship program to ensure a safe and sustainable use of the Tolerant Product and Product Herbicide, where
                    separate agreements will be required to be entered into with such third parties to govern responsibilities and liabilities. The stewardship program shall be reviewed annually in line with the Development Plan.

                 

                  

              

      

    

    
      
        	

              	(4)	
                Pricing. Every year on or before August 1st, and to be included in the Development Plan, the
                    Parties shall review the pricing of Tolerant Product and Product Herbicide (defined as seed premium or seed royalties from third parties and herbicide costs) which will be used as a basis for any adjustments in the market and for third
                    party licensees.

                 

                  

              

      

    

    
      
        	

              	(5)	
                Costs.  Any out of pocket costs and expenses incurred to fulfill obligations and
                    responsibilities under this Agreement for the Marketing Collaboration Term shall be borne initially by that Party incurring such cost or expense. However, it has been agreed between the Parties that in consideration of Rotam’s support
                    to Cibus with the promotion of Product Herbicide for Tolerant Product in the Territory as agreed to by the Commercialization Committee, Cibus shall reimburse Rotam 50% of its out of pockets costs/expenses (excluding salary expenses)
                    pursuant to the agreed budget in Section 5.3(c)(8). Such out of pocket costs would include marketing, advertising, promotional, and costs related to regulatory matters that are directly associated to the maintenance and sustainability
                    of Product Herbicide Registrations for use on the Tolerant Product. The amount Cibus reimburses Rotam shall not exceed 50% of the relevant costs per the agreed budget pursuant to Section 5.3(c)(8).

              

      

    

    
      8

      
        

    

    

    

    
      
        	

              	(6)	
                Forecast.  Every year on or before August 1st, and to be included in the Development Plan, the
                    Parties will determine the sales forecast of Tolerant Product and third-party branded seed pursuant to Section 2.5 for the following season. This will enable Rotam to assess the production planning of Tolerant Product for its supply
                    forecast of the Product Herbicide.

                 

                  

              

      

    

    
      
        	

              	(7)	
                Technical Support.  Every year on or before August 1st and to be included in the Development
                    Plan, the Parties shall discuss and agree on any field technical support, field sales training, and any other required technical support necessary for the Purpose.

                 

                  

              

      

    

    
      
        	

              	(8)	
                Budget.  Every year on or before 1st August, the Parties will agree to a budget for the
                    following year for costs including bags of seeds and herbicide requirements, with additional approvals if required by a Party’s “Delegation of Authority” policy.

                 

                  

              

      

    

    
      
        	

              	(9)	
                Immediate Two (2) Year Plan.  The Commercialization Committee will also establish and implement
                    a two (2) year plan within three (3) months of the Effective Date and to be reviewed each year with the aim to address immediate matters to implement the Purpose. This will include more detailed and accurate actions such as market
                    discussions and market share, sales of seeds and chemicals, all aspects of costs and value sharing. The purpose of this two (2) year plan is to ensure that steps are in place to ensure growth of the Development Plan and to detail the
                    imminent responsibilities of the Parties.

                 

                  

              

      

    

    
      
        	

              	(10)	
                Cibus Branded Seeds / Tolerant Product. The Parties shall under the Development Plan, determine
                    the most appropriate market and distribution strategy in the Territory for the interest of the Parties in securing optimal sales in Tolerant Product and Product Herbicide. Rotam shall therefore actively participate in the sales and
                    promotion of such Tolerant Product. In doing so, Rotam shall be reimbursed in accordance with Section 5.3(c)(5) for its out of pocket expenses incurred.

                 

                  

              

      

    

    
      
        	

              	(d)	
                Conclusion of Commercialization Committee. Upon expiration or termination of the Marketing
                    Collaboration Term, the Commercialization Committee will be dis-banded and Section 5.3(c) is deleted in its entirety and is of no further force or effect.

              

      

    

    
      9

      
        

    

    

    

    ARTICLE 6.   PRODUCT HERBICIDE
            SUPPLY

     

          

    
      
        	6.1.	
                During the Supply Term, Cibus agrees that all of their requirement for the Product Herbicide for use with Cibus branded seed Tolerant Product will be sourced from Rotam.

                 

                  

              

      

    

    
      
        	6.2.	
                Commencing for the 2019-2020 growing season, on or before August 1st (of each year), Cibus shall provide Rotam with a two (2) year seed production forecast (which is the
                    estimated yield of seed produced by third party seed production contractors) of the quantity of Tolerant Product. Rotam will forecast the corresponding quantity of Product Herbicide to be used in conjunction with Tolerant Product.

                 

                  

              

      

    

    
      
        	6.3.	
                Cibus will re-confirm its seed production forecast in one (1) year periods on an annual basis and by October 1st of each year providing a more definitive seed production
                    forecast quantity, which is to be agreed between the Parties within seven (7) days. Once the annual forecast of Tolerant Product and Product Herbicide is agreed to between the Parties, Rotam shall be obligated to supply the annual
                    forecast of the Product Herbicide between a delivery time of 1 March (earliest) and 30 April (latest) of the following year.

                 

                  

              

      

    

    
      
        	6.4.	
                Should Cibus require any quantity of the Product Herbicide above the agreed forecast, Cibus shall notify Rotam as soon as reasonably practicable in order to meet delivery
                    times (as provided in Section 6.3) and Rotam shall confirm its ability to meet the additional quantity requirement within five (5) business days of the request. Rotam shall do its utmost to meet the additional requirements above the
                    forecast for requests received after October 1st and before November 15th.
                    Any additional forecast requirements received after November 15th can still be requested by Cibus but cannot be guaranteed for supply by Rotam. However,
                    Rotam will endeavour to fulfil the needs of Cibus for any forecasts received after November 15th. Once the additional quantity requirement has been
                    accepted by Rotam, Rotam shall be obligated to ensure the additional supply of the Product Herbicide above the agreed forecast.

                 

                  

              

      

    

    
      
        	6.5.	
                In the event where Rotam cannot supply the quantity of the Product Herbicide pursuant to Sections 6.3 and 6.4 once the forecast has been agreed, Rotam shall inform Cibus
                    immediately following receipt of Cibus’ re-confirmed annual forecast, and the use of the supplemental registration under Section 6.7 will be activated.

              

      

    

    
      10

      
        

    

    

    

    
      
        	6.6.	
                In the event where Cibus determines that it cannot meet the annual seed production forecast of Tolerant Product following Rotam’s acceptance to supply the agreed amount of
                    Product Herbicide, Cibus shall inform Rotam immediately where Rotam shall make Commercially Reasonable Efforts to divert inventory of the Product Herbicide to other markets. If Rotam is unable to divert inventory of the Product
                    Herbicide within the current season and the final seed production forecast of Tolerant Product is lower than 85% of the agreed to annual seed production forecast, Cibus acknowledges Rotam’s direct out of pocket costs (i.e., warehousing,
                    relabeling, freight, and annualized interest of working capital costs) for producing the inventory of Product Herbicide. Cibus will compensate Rotam for the annualized interest (i.e., prime interest rate based on the Wall Street Journal
                    for that year) based on a $4.00 CAN per acre invoice price to distribution of the undiverted inventory of Product Herbicide (which is the difference between the final seed production forecast of Tolerant Product and 85% of the agreed
                    (including any additional) seed production forecast of Tolerant Product). The Parties will agree to the amount of undiverted inventory of Product Herbicide for which Rotam will then invoice Cibus. Cibus will compensate Rotam twelve (12)
                    months after Cibus receipt of invoice (i.e., in the following season). As an example, if the undiverted inventory of Product Herbicide was to treat 100,000 acres and assuming the Wall Street Journal prime interest rate was 6.00%, then
                    Cibus would pay Rotam $24,000 CAN (calculated as [100,000 acres * $4.00 CAN/acre] * 6.00%).

                 

                  

              

      

    

    
      
        	6.7.	
                Supplemental Registration of Product Herbicide.

                 

                  

              

      

    

    
      
        	

              	(a)	
                Rotam will ensure the grant of a US EPA supplemental registration of Volta Extra (DraftTM) herbicide to Cibus within six (6) months of the Effective Date of this Agreement
                    and the grant of a Canada PMRA repack label registration within twelve (12) months of the Effective Date. These registrations and associated labels are only
                    to be used by Cibus pursuant to Section 6.5 where Rotam is no longer or not able to supply Cibus’ needs for Volta Extra (DraftTM) herbicide or other registered SU herbicide for use on Tolerant Product pursuant to this Agreement. Rotam
                    agrees to maintain the registration of its Product Herbicide in active status (unless cancelled or revoked by the EPA or PMRA) and pay all required fees and other cost associated with the registrations, except that US state and any
                    Canadian provincial registration fees for the supplemental and repack registrations will be paid by Cibus.

              

      

    

    

    

    
      
        	

              	(b)	
                Should Cibus need to activate and use the supplemental registration pursuant to Section 6.7 (a), written notification must be provided to Rotam and Rotam agrees to supply
                    Cibus with Herbicide Product at a price that is Commercially Reasonable and consistent with a price it receives for Volta Extra (DraftTM) herbicide and other similar SU products to other existing supplemental registrants.  If no such
                    supplemental registrant exists, then the Parties will negotiate in good faith and agree upon a price within thirty (30) days.

              

      

    

    

    

    
      11

      
        

    

    

    

    
      
        	

              	(c)	
                The grant of the supplemental registration pursuant to Section 6.7 (a) is for the benefit of Cibus only and in consideration of this, Cibus agrees not to directly or
                    indirectly work with any existing or future third party Product Herbicide Registration holders and Rotam agrees that should it for any reason not be able to supply Cibus with the Herbicide Product pursuant to Section 6.7 (b), Rotam
                    agrees to use its best endeavours to refer/align a third party technical source and formulated product for Canada PMRA and US EPA registrations and assist by using its industry knowledge (US EPA and Canada PMRA, manufacturing,
                    formulation, and sourcing).

              

      

    

    

    

    
      
        	

              	(d)	
                During the period where the supplemental registration is activated, Rotam will endeavour to support and meet the requirements of Cibus. The supplemental registration will
                    remain in force until Rotam confirms in writing its ability to be able to resume the forecast supply requirements of the Product Herbicide. Rotam will resume its obligations of supply in the following season in accordance with the
                    forecast provided by Cibus. For any Product Herbicide that Cibus has as carryover inventory, Rotam has the option, but not the obligation, to purchase the carryover inventory. The Parties agree to negotiate in good faith the price that
                    Rotam will pay Cibus for carryover inventory. If the Parties cannot reach a settlement within thirty (30) days, then the matter will be referred to senior officials in accordance with Section 10.1 requiring for it to be remedied. If no
                    settlement can then be reached within an additional thirty (30) days, then Cibus will be permitted to clear any inventory of stock committed with the supplemental registration up to a maximum period to the end of the following season.
                    Once the inventory of stock under the supplemental registration has been cleared or Cibus has reached the end of the following season to clear the stock (whichever is sooner), the supplemental registration will be suspended and Cibus
                    and/or Rotam will if required or by regulation, complete any documentation or notify the regulatory authorities of such.

              

      

    

    

    

    ARTICLE 7.   TERMINATION

     

          

    
      
        	7.1.	
                This Agreement may be terminated mutually by the Parties.

                 

                  

              

      

    

    
      
        	7.2.	
                Either Party may terminate this Agreement immediately and without liability, except to the extent that obligations and liabilities have accrued prior to such termination or
                    representations or warranties survive any such termination herein only in the following circumstances:

                 

                  

              

      

    

    
      
        	

              	(a)	
                where the other Party becomes insolvent or bankrupt within the meaning of the Bankruptcy Code, or reorganizes its business under or takes advantage of as a debtor any
                    bankruptcy or insolvency laws or shall take steps or have steps taken against it for the winding up or reorganization of its corporate or business entity existence, or shall have a receiver, trustee or other officer appointed for its
                    property and such receiver, trustee or other officer is not removed within thirty (30) days of its appointment; or

              

      

    

    

    

    
      12

      
        

    

    

    

    
      
        	

              	(b)	
                where the other Party fails to perform, commits any continuing material breach or violates any material obligation under this Agreement, and in case of such a breach which
                    is capable of remedy, fails to remedy the same within sixty (60) days’ after receipt of a written notice giving full particulars of the breach and having referred the matter to senior officials in accordance with Section 10.1 requiring
                    for it to be remedied.

              

      

    

    

    

    
      
        	7.3.	
                Expiry or termination of the Marketing Collaboration Term does not render an automatic termination of the Supply Term. Should the Marketing Collaboration Term and its
                    provisions be terminated between the Parties, the Supply Term with its provisions under this Agreement will survive.

                 

                  

              

      

    

    ARTICLE 8.   INSURANCE

     

          

    
      
        	8.1.	
                Without in any way limiting a Party’s responsibility or liability under any indemnification or hold harmless requirements of this Agreement, the Parties shall, at its own
                    expense, carry and maintain insurance with companies rated by A. M. Best with a rating of at least A or the equivalent for its own purposes, as follows:

                 

                  

              

      

    

    
      
        	

              	(a)	
                Both Parties shall obtain/have “Worker’s Compensation and Employer’s Liability Insurance” or the equivalent in minimum amounts prescribed by applicable law;

                 

                  

              

      

    

    
      
        	

              	(b)	
                Both Parties shall obtain/have comprehensive “General Liability (Bodily Injury and Property Damage) Insurance, including Broad Form Property Damage Liability Insurance and
                    Product Liability Insurance” or the equivalent;

                 

                  

              

      

    

    
      
        	

              	(c)	
                The limits of liability of each insurance policy mentioned above shall be no less than one million dollars ($1,000,000).

                 

                  

              

      

    

    
      
        	8.2.	
                Both Parties shall furnish the other Party satisfactory evidence that such insurance is in effect within sixty (60) business days of the Effective Date and each year
                    thereafter on the annual anniversary date of the Agreement.

              

      

    

    
      13

      
        

    

    

    

    ARTICLE 9.   CONFIDENTIALITY

    
      
        	9.1.	
                Non-disclosure Obligations

                 

                      

              

      

    

    
      
        	

              	(a)	
                Except as otherwise provided herein, during the Marketing Collaboration Term and/or Supply Term and for a period of ten (10) years after the end of the latter of the
                    Marketing Collaboration Term or the Supply Term thereafter, each Party shall maintain in confidence all Confidential Information, disclose such Confidential Information only on a “need to know” basis as necessary to carry out the
                    responsibilities and obligations of this Agreement, and use such Confidential Information disclosed by the other Party only for the Purpose of this Agreement, provided that trade secrets shall be maintained in perpetuity.

                 

                  

              

      

    

    
      
        	

              	(b)	
                The obligation not to disclose or use Confidential Information will not apply to any Confidential Information that: (a) is or becomes patented, published or otherwise part
                    of the public domain other than by acts of the Party obligated not to disclose such information by this Agreement; (b) is disclosed to the receiving Party by a third party, provided such information was not obtained by such third party
                    directly or indirectly from the other Party under this Agreement on a confidential basis; (c) was already in the possession of the receiving Party prior to its disclosure under this Agreement, provided such information was not obtained
                    directly or indirectly from the other Party in anticipation of this Agreement; or (d) is independently discovered or developed by the receiving Party and without the use of, or access, reliance or reference to, the disclosing Party’s
                    Confidential Information, as can be documented by contemporaneously written records.

                 

                  

              

      

    

    
      
        	

              	(c)	
                If Confidential Information is required to be disclosed by any judicial order or decree or any governmental law or regulation, an appropriate and timely notice thereof
                    shall be given by the Party required to disclose Confidential Information to the other Party so as to allow the other party the opportunity to obtain appropriate protection from the relevant governmental or judicial entity if such
                    Confidential Information relates to the other Party. The Parties acknowledge that the filing of the Agreement with the U.S. Securities and Exchange Commission may be required in connection with any public offering of securities by
                    either Party, and the Parties hereby consent thereto.

                 

                  

              

      

    

    
      
        	9.2.	
                Permitted Disclosures

                 

                      

              

      

    

    
      
        	

              	(a)	
                Only insofar as necessary to fulfill obligations or exercise rights under this Agreement, a Party may disclose to its Affiliates, sublicensees, consultants, and outside
                    contractors, on a need-to-know basis, Confidential Information on condition that such persons agree to keep such Confidential Information confidential for the same time periods and to the same extent as the disclosing Party is required
                    to keep such information confidential pursuant to this Agreement.

                 

                  

              

      

    

    
      14

      
        

    

    

    

    
      
        	

              	(b)	
                A Party may disclose Confidential Information to government or other regulatory authorities to the extent that such disclosure is required by applicable law, regulation or
                    court order, or is reasonably necessary to obtain patents or authorizations under which to conduct regulatory trials, provided that the disclosing Party provides written notice to the other Party prior to disclosure and sufficient time
                    to allow the Party a reasonable opportunity to object thereto.

                 

                  

              

      

    

    
      
        	

              	(c)	
                Except as provided herein, neither Party shall use the name or any Confidential Information of the other Party in any advertising or promotional material or in any
                    publication or presentation without the prior written consent of the other Party, wherein said consent shall not be unreasonably withheld. Notwithstanding the foregoing, the Parties may make one or more press releases regarding this
                    Agreement, either jointly or separately, provided that any such press release and its content has been mutually agreed upon in writing by the Parties. Each Party may subsequently use the information contained within any approved press
                    release for further disclosure without obtaining consent of the other Party.

                 

                  

              

      

    

    ARTICLE 10.   DISPUTE
            RESOLUTION

     

          

    
      
        	10.1.	
                The Parties recognize that a bona fide dispute as to any matters arising out of or relating to the subject of this Agreement (including its validity, amendment, waiver or
                    termination, and the consequences thereof) (a “Dispute”) may from time to time arise during or after the term of this Agreement. In the event of
                    the occurrence of such a Dispute, either Party may, by notice to the other Party, have such Dispute referred to their respective senior officials, for attempted resolution by good faith negotiations within sixty (60) days after such
                    notice is received (“Negotiation Period”).  The Negotiation Period may be extended only by mutual written consent of the Parties.

                 

                  

              

      

    

    
      
        	10.2.	
                Binding Arbitration

                 

                      

              

      

    

    
      
        	

              	(a)	
                In the event that an agreement is not reached during the Negotiation Period, either Party may refer the Dispute for resolution.

                 

                  

              

      

    

    
      
        	

              	(b)	
                Unless the Parties agree on a different set of arbitration rules, the arbitration shall be governed by the United States Arbitration Act, 9 U.S.C 1 et seq. and conducted by
                    a single arbitrator in accordance with the Commercial Rules of the American Arbitration Association (“AAA”).  If the Parties are unable to agree
                    upon the arbitrator, the arbitrator shall be selected by the AAA. The arbitrator selected shall have experience in both the seed industry and the agricultural chemicals industry.  The arbitrator shall be selected and shall convene the
                    arbitration within one (1) month from the end of the Negotiation Period. Such arbitration shall take place in Wilmington, Delaware or its vicinity provided, however, that the arbitrator may conduct hearings at such other location as he
                    finds appropriate for the convenience of the Parties, and deposition testimony may be taken, as permitted hereunder, at such other location or locations as shall be for the mutual convenience of the Parties. Unless otherwise agreed by
                    the Parties, the arbitration shall be conducted in the English language.

              

      

    

    
      15

      
        

    

    

    

    
      
        	

              	(c)	
                Discovery shall be limited for each Party to not more than two (2) depositions of potential witnesses, each not more than five (5) hours in duration, three (3)
                    interrogatories, each of not more than twenty (20) questions including sub-parts, production of directly relevant documents, and physical examination.  Additional discovery shall be in the discretion of the arbitrator. All discovery
                    shall be completed within two (2) months of selection of the arbitrator, unless the period is extended by the arbitrator for good cause.

                 

                  

              

      

    

    
      
        	

              	(d)	
                The arbitration hearing, if necessary, shall commence no later than one (1) month after the close of discovery and no more than one (1) day shall be allotted for that
                    hearing, unless the arbitrator determines that justice requires otherwise.

                 

                  

              

      

    

    
      
        	

              	(e)	
                The parties may file a pre-hearing brief of not more than twenty-five (25) pages which must be submitted to the arbitrator and opposing party no later than the fifth
                    business day prior to commencement of the hearing.  The parties may file a post-hearing brief of not more than twenty-five (25) pages which must be submitted to the arbitrator and opposing party no later than the fifth business day
                    following the close of the hearing.

                 

                  

              

      

    

    
      
        	

              	(f)	
                The arbitrator shall base his decision on the terms and conditions of the Agreement, as interpreted according to the substantial law and judicial precedent of the State of
                    Delaware.  The decision of the arbitrator hall be final and binding, and judgment upon the award rendered by the arbitrator may be entered by any court of competent jurisdiction.  The decision of the arbitrator shall be in the form of a
                    written decision rendered within thirty (30) days after the conclusion of the arbitration hearing, such written decision to include the findings of fact and conclusions of law upon which it is based.  The arbitrator shall be empowered
                    to grant any award in law or equity including, but not limited to, monetary damages (which shall be limited to compensatory damages only), injunctive relief, including temporary restraining orders prior to rendering a final judgment,
                    and reasonable attorney’s fees.

                 

                  

              

      

    

    
      
        	

              	(g)	
                Notwithstanding the foregoing, no controversy or claim requiring a judgment as to the validity, scope, applicability, enforceability or infringement of any Patent shall be
                    resolved by arbitration under this Article.

                 

                  

              

      

    

    
      
        	

              	(h)	
                No arbitration or litigation shall be commenced between the Parties prior to or during the Negotiation Period, except for equitable remedies such as injunctive relief or
                    specific performance.

                 

                  

              

      

    

    
      
        	

              	(i)	
                The agreement to arbitrate contained in this Article 10 shall continue in full force and effect despite the expiration or termination of this Agreement.

              

      

    

    
      16

      
        

    

    

    

    ARTICLE 11.   OTHER TERMS

            

          

    
      
        	11.1.	
                Notices.  Any consent, notice or report required or permitted to be given or made under this
                    Agreement by one of the Parties to the other will be in writing, delivered personally and promptly confirmed by personal delivery, first class mail or courier, addressed to such other Party at its address indicated below, or to such
                    other address as the addressee will have last furnished in writing to the addressor and will be effective upon receipt by the addressee.

                 

                  

              

      

    

    
      
        	

              	If to CIBUS:	
                CIBUS

                    6455 Nancy Ridge Drive

                    San Diego, California 92121, USA

                    Attention:  President and CEO

                 

                  

              

      

    

    
      
        	

              	If to ROTAM:	
                 ROTAM GLOBAL AGROSCIENCES LIMITED

                    26/F, E-Trade Plaza, 24 Lee Chung Street, Chai Wan, HK

                    Attention: CEO

                 

                  

              

      

    

    
      
        	
                11.2.

              	
                Governing Law. Except with respect to the validity and enforceability of intellectual property
                    rights, which will be governed by the laws of the jurisdiction granting said rights, this Agreement will be governed by and construed in accordance with the laws of Delaware without regard to the conflicts of law principles thereof.

                 

                  

              

      

    

    
      
        	11.3.	
                Entire Agreement.  Except for the Product Herbicide Label, this Agreement, all Schedules
                    attached hereto, and any invoices issued pursuant to this Agreement constitute the entire agreement between the Parties, superseding all prior oral or written representations, negotiations, understandings and agreements on the subject
                    matter hereof; and there are no conditions to this Agreement which are not expressed herein.  All Schedules, invoices, and properly executed amendments are incorporated herein by reference.

                 

                  

              

      

    

    
      
        	11.4.	
                Counterparts.  The Agreement may be executed in two or more counterparts, each of which will be
                    deemed an original, but all of which together will constitute one and the same instrument.

                 

                  

              

      

    

    
      
        	11.5.	
                Amendments.  This Agreement may be amended only by a writing signed by both Parties.

                 

                  

              

      

    

    
      
        	11.6.	
                Assignment and Successors.  Neither Party may assign or otherwise transfer its obligations
                    under this Agreement or any interest herein or any right without the prior written consent of the other Party, except to its Affiliates or in the event of a sale of either Party’s entire business related to the Purpose. In such a sale
                    of a Party’s entire business, all obligations, liabilities and responsibilities will be transferred and undertaken by the new party.

              

      

    

    
      17

      
        

    

    

    

    
      
        	11.7.	
                Severability.  In the event that any provisions of this Agreement are determined to be invalid
                    or unenforceable by a court of competent jurisdiction, the remainder of this Agreement will remain in full force and effect without the provision.  The Parties will in good faith negotiate a substitute clause for any provision declared
                    invalid or unenforceable, which will most nearly approximate the intent of the Parties in entering this Agreement.

                 

                  

              

      

    

    
      
        	11.8.	
                Force Majeure.  Neither Party shall be held liable or responsible to the other Party nor be
                    deemed to have defaulted under or breached this Agreement for failure or delay in fulfilling or performing any term of this Agreement to the extent, and for so long as, such failure or delay is caused by or results from causes beyond
                    the reasonable control of the affected Party including but not limited to fire, floods, embargoes, war, acts of war (whether war be declared or not), terrorist acts, insurrections, riots, civil commotions, strikes, lockouts or other
                    labor disturbances, acts of God or acts, omissions or delays in acting by any governmental authority or other parties.

                 

                  

              

      

    

    
      
        	11.9.	
                Headings.  The captions to the several Articles, and Paragraphs hereof are not a part of the
                    Agreement, but are merely guides or labels to assist in locating and reading the several Articles, and Paragraphs hereof.

                 

                  

              

      

    

    
      
        	11.10.	
                Waiver.  The waiver by a Party of any right hereunder or the failure to perform or of a breach
                    by such Party will not be deemed a waiver of any other right hereunder or of any other breach or failure by such Party, whether of a similar nature or otherwise.

                 

                  

              

      

    

    
      
        	11.11.	
                Adverse Effects Reporting.  If either Party becomes aware of any unreasonable adverse effects
                    on human health or the environment concerning Product Herbicide, the Party shall immediately inform the other Party of such information and shall provide the Party with all information concerning such unreasonable adverse effect(s) as
                    may be required by FIFRA 6 (a) 2.

              

      

    

    
      18

      
        

    

    

    

    IN WITNESS THEREOF, this Agreement has been signed for and on behalf
        of the Parties on the dates set forth below.

    

    

    

    

    	
            Cibus US LLC

          	 	
            Amaethon Environmental Limited

          
	 	 	 
	 	 	 
	
            /s/ Peter Beetham

          	 	
            /s/ James Briston

          
	
            Printed Name: Peter Beetham, Ph.D.

          	 	
            Printed Name: James Briston

          
	
            Title: President & Chief Executive Officer

          	 	
            Title: Director

          
	
            Date: December 18, 2018

          	 	
            Date: December 19, 2018

          
	 	 	 
	 	 	 
	
            Cibus Europe B.V.

          	 	 
	 	 	 
	/s/ Carlos Broos

          	 	 
	
            Printed Name: Carlos Broos

          	 	 
	
            Title: Director

              

          	 	 
	
            Date: December 19, 2018

              

          	 	 

     

    

    

    

  

  19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]